Antifungals: mechanism of action and resistance, established and novel drugs (Q33538696)

27 July 2017

1 reference

title

Antifungals: mechanism of action and resistance, established and novel drugs (English)

1 reference

27 July 2017

Georgopapadakou NH

1

1 reference

27 July 2017

publication date

1 October 1998

1 reference

Current Opinion in Microbiology

27 July 2017

published in

1 reference

27 July 2017

volume

1

1 reference

27 July 2017

issue

5

1 reference

27 July 2017

page(s)

547-557

1 reference

Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Human mycoses: drugs and targets for emerging pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Nosocomial pneumonia in patients having bone marrow transplant attributable mortality and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Treatment of infection due to Pneumocystis carinii

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Effects of antifungal agents on the function of human neutrophils in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Effects of naftifine and terbinafine, two allylamine antifungal drugs, on selected functions of human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Molecular mechanisms of drug resistance in fungi

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Lipid formulations for amphotericin B: does the emperor need new clothes?

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Amphotericin B: new life for an old drug

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol delta5,6-desaturation

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Overview of medically important antifungal azole derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Antifungal agents: chemotherapeutic targets and immunologic strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Increased sensitivity of Candida albicans cells accumulating 14 alpha-methylated sterols to active oxygen: possible relevance to in vivo efficacies of azole antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Resistance of Candida species to fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Failure of fluconazole treatment in cryptococcal meningitis despite adequate CSF levels

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Molecular genetic studies on the mode of action of azole antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Resistance of Candida albicans to azole antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Multiple resistance mechanisms to azole antifungals in yeast clinical isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Saccharomyces cerevisiae ABC proteins and their relevance to human health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Multidrug-resistant transport proteins in yeast: complete inventory and phylogenetic characterization of yeast open reading frames with the major facilitator superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Mechanism of action and biochemical selectivity of allylamine antimycotic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Squalene epoxidase as a target for the allylamines

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Effects of squalene epoxidase inhibitors on Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Evolving role of flucytosine in immunocompromised patients: new insights into safety, pharmacokinetics, and antifungal therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Flucytosine--what is its future?

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Cell wall integrity modulates RHO1 activity via the exchange factor ROM2

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Rho1p, a yeast protein at the interface between cell polarization and morphogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Identification of yeast Rho1p GTPase as a regulatory subunit of 1,3-beta-glucan synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

A conserved kinase cascade for MAP kinase activation in yeast.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

A downstream target of RHO1 small GTP-binding protein is PKC1, a homolog of protein kinase C, which leads to activation of the MAP kinase cascade in Saccharomyces cerevisiae.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Mutants in the S. cerevisiae PKC1 gene display a cell cycle-specific osmotic stability defect

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The fungal cell wall as a drug target

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Critical steps in fungal cell wall synthesis: strategies for their inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Antibiotics that inhibit fungal cell wall development

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Echinocandins and pneumocandins--a new antifungal class with a novel mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Genetics and molecular biology of chitin synthesis in fungi

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Differential inhibition of chitin synthetases 1 and 2 from Saccharomyces cerevisiae by polyoxin D and nikkomycins

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Nikkomycin Z is a specific inhibitor of Saccharomyces cerevisiae chitin synthase isozyme Chs3 in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Attenuated virulence of chitin-deficient mutants of Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

In vitro and in vivo antifungal activities of BMS-181184

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

In vitro antifungal and fungicidal spectra of a new pradimicin derivative, BMS-181184

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Studies on the mode of antifungal action of pradimicin antibiotics. II. D-mannopyranoside-binding site and calcium-binding site.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Antifungals targeted to the cell wall

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Inhibitors of sterol biosynthesis and their applications

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The search for new triazole antifungal agents

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Conservation between human and fungal squalene synthetases: similarities in structure, function, and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Translation elongation factor 3: a fungus-specific translation factor?

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The elongation factor 3 unique in higher fungi and essential for protein biosynthesis is an E site factor

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Identification and kinetic analysis of a functional homolog of elongation factor 3, YEF3 in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Isolation and Characterisation of an Antifungal Antibiotic (GR135402) with Protein Synthesis Inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Genetic and biochemical studies of protein N-myristoylation

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Genetic studies reveal that myristoylCoA:protein N-myristoyltransferase is an essential enzyme in Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Crystal structure of the anti-fungal target N-myristoyl transferase

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifung

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Is there a role for GPIs in yeast cell-wall assembly?

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

In silicio identification of glycosyl-phosphatidylinositol-anchored plasma-membrane and cell wall proteins of Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Fumonisins: fungal toxins that shed light on sphingolipid function

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The discovery of australifungin, a novel inhibitor of sphinganine N-acyltransferase from Sporormiella australis. Producing organism, fermentation, isolation, and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The AUR1 gene in Saccharomyces cerevisiae encodes dominant resistance to the antifungal agent aureobasidin A (LY295337).

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Structure of aureobasidin A

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Khafrefungin, a novel inhibitor of sphingolipid synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The galbonolides. Novel, powerful antifungal macrolides from Streptomyces galbus ssp. eurythermus

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Rustmicin, a potent antifungal agent, inhibits sphingolipid synthesis at inositol phosphoceramide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Antimitotic agents: chemistry and recognition of tubulin molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

DNA topoisomerases from pathogenic fungi: targets for the discovery of antifungal drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Selective inhibition of topoisomerases from Pneumocystis carinii compared with that of topoisomerases from mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Identification of the aminocatechol A-3253 as an in vitro poison of DNA topoisomerase I from Candida albicans

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Identification of a new antifungal target site through a dual biochemical and molecular-genetics approach

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Cispentacin, a new antifungal antibiotic. I. Production, isolation, physico-chemical properties and structure

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Cispentacin, a new antifungal antibiotic. II. In vitro and in vivo antifungal activities

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Anti-Candida activity of cispentacin: the active transport by amino acid permeases and possible mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

The mechanism of antifungal action of (S)-2-amino-4-oxo-5-hydroxypentanoic acid, RI-331: the inhibition of homoserine dehydrogenase in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

A new methionine antagonist that has antifungal activity: mode of action.

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Ornithine decarboxylase as an enzyme target for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Ornithine decarboxylase in Pneumocystis carinii and implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Fungal plasma membrane proton pumps as promising new antifungal targets

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Genetics and biochemistry of yeast multidrug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

Emerging targets for the development of novel antifungal therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1369-5274%2898%2980087-8

7 January 2021

10.1016/S1369-5274(98)80087-8

Identifiers

DOI

1 reference

27 July 2017

1 reference